Valneva announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ®
Valneva SE announced that the FDA has removed its recommended pause in the use of IXCHIQ in individuals 60 years of age and older and has approved updates to the Prescribing Information for IXCHIQ.




















